I'm also familiar with the industry. At what level are the cure being limited? Are Pharma scientists not looking for curative potentially approaches? or maybe ditching promising candidates precinically? are Pharma ClinDev folks designing studies for cures to intentionally fail maintaining demain for their chronic drugs? Did GIlead miss the opportunity to break cure they spent all that cash on? the I'm having a hard time understanding the specifics of how this strategy is executed. There is MUCH wrong with the pharma industry.The noise of conspiracy theories can dilute legitimate criticisms that could lead to corrective pressures.